Literature DB >> 16501997

Expression patterns and novel splicing variants of glutathione-S-transferase isoenzymes of human lung and hepatocyte cell lines.

Mario Bauer1, Olf Herbarth, Gabriela Aust, Jan G Hengstler, Anja Dotzauer, Carolin Graebsch, Eike Schmuecking.   

Abstract

Polymorphic glutathione S-transferase (GST) enzymes are involved in the metabolism of xenobiotics. They are of particular interest when studying disease susceptibility and adverse drug responses. The present work deals with the genetic polymorphisms and expression of the five GST classes (alpha, mu, pi, theta and zeta) in human lung and hepatocyte cell lines. We have determined their bioavailability for in vitro approaches. Common genetic polymorphisms of GSTM1 (*0, null), GSTT1 (*0) and GSTP1 (*A/*B, I105V) are detectable. The frequencies of the polymorphisms are within the expected range for a Caucasian population with one exception. The GSTM1*0 allele is 1.5-fold more frequent in lung cell lines. GST mRNAs are frequently but not uniformly distributed among unstimulated in vitro conditions. Lung cell lines show an approximately six-fold higher total GST transcript expression than hepatocyte cell lines. Additional GST transcripts have been identified for GSTT1; they represent alternative new splicing variants that occur in cancerous cell lines and in healthy lung tissue and blood. GST enzyme activity is mainly influenced by GSTP1. The activity promoted by 1-chloro-2,4-dinitrobenzene is significantly correlated to the GSTP1 mRNA expression level (R2=0.77, P<0.001). Individual human cell lines thus express GST isoenzymes in a similar pattern to human tissue. The most common genetic polymorphisms are present among the cell lines and have to be considered for in vitro stimulation approaches in a combinatory pattern.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16501997     DOI: 10.1007/s00441-005-0150-8

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  6 in total

1.  Disinfection by-products exposure and intra-uterine growth restriction: Do genetic polymorphisms of CYP2E1or deletion of GSTM1 or GSTT1 modify the association?

Authors:  Patrick Levallois; Yves Giguère; Molière Nguile-Makao; Manuel Rodriguez; Céline Campagna; Robert Tardif; Alexandre Bureau
Journal:  Environ Int       Date:  2016-04-22       Impact factor: 9.621

2.  Downregulation of glutathione S-transferase pi in asthma contributes to enhanced oxidative stress.

Authors:  Kathy T Schroer; Aaron M Gibson; Umasundari Sivaprasad; Stacey A Bass; Mark B Ericksen; Marsha Wills-Karp; Tim Lecras; Anne M Fitzpatrick; Lou Ann S Brown; Keith F Stringer; Gurjit K Khurana Hershey
Journal:  J Allergy Clin Immunol       Date:  2011-05-13       Impact factor: 10.793

3.  Traffic, asthma and genetics: combining international birth cohort data to examine genetics as a mediator of traffic-related air pollution's impact on childhood asthma.

Authors:  Elaina A MacIntyre; Christopher Carlsten; Meaghan MacNutt; Elaine Fuertes; Eric Melén; Carla M T Tiesler; Ulrike Gehring; Ursula Krämer; Claudia Klümper; Marjan Kerkhof; Moira Chan-Yeung; Anita L Kozyrskyj; Dietrich Berdel; Carl Peter Bauer; Olf Herbarth; Mario Bauer; Beate Schaaf; Sibylle Koletzko; Goran Pershagen; Bert Brunekreef; Joachim Heinrich; Michael Brauer
Journal:  Eur J Epidemiol       Date:  2013-07-24       Impact factor: 8.082

4.  Microsomal epoxide hydrolase, glutathione S-transferase P1, traffic and childhood asthma.

Authors:  Muhammad T Salam; Pi-Chu Lin; Edward L Avol; W James Gauderman; Frank D Gilliland
Journal:  Thorax       Date:  2007-08-21       Impact factor: 9.139

5.  Asthmatic airway neutrophilia after allergen challenge is associated with the glutathione S-transferase M1 genotype.

Authors:  Aimee Hoskins; Sara Reiss; Pingsheng Wu; Ning Chen; Wei Han; Rui-hong Do; Rasul Abdolrasulnia; Ryszard Dworski
Journal:  Am J Respir Crit Care Med       Date:  2012-11-29       Impact factor: 21.405

6.  Gene expression analysis of membrane transporters and drug-metabolizing enzymes in the lung of healthy and COPD subjects.

Authors:  Tove Berg; Tove Hegelund Myrbäck; Marita Olsson; Janeric Seidegård; Viktoria Werkström; Xiao-Hong Zhou; Johan Grunewald; Lena Gustavsson; Magnus Nord
Journal:  Pharmacol Res Perspect       Date:  2014-06-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.